Matthew R. Henn Seres Therapeutics, Inc. (MCRB) insider trading activity
Matthew R. Henn is of Seres Therapeutics, Inc.. Currently has a direct ownership of 65,357 shares of MCRB, which is worth approximately $49,017. The most recent transaction as insider was on May 15, 2024, when has been sold 891 shares (Common Stock) at a price of $0.94 per share, resulting in proceeds of $837. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
65.4K
3.03%
3M change
37.25%
12M change
Total Value Held
$49,017
Matthew R. Henn Transaction History
MRH
Matthew R. Henn
Cambridge, MA